Mary Canady, Ph.D. is the founder of Comprendia, a firm specializing in helping biotechnology and life science companies grow through the creation, commercialization, and communication of value. She has a Ph.D. in Biochemistry and 10 years of direct experimental experience at Duke University, University of California Riverside, and The Scripps Research Institute. In 2000, Mary left academia and has worked in marketing and business development roles at Invitrogen, EMD Biosciences, and ActiveSight (Rigaku). In 2008, she founded the San Diego Biotechnology Network, a grass roots organization using online and face-to-face interactions to promote growth in the region. Mary is passionate about engaging scientists and biotechnology professionals with new tools such as social media and has become a recognized thought leader in the area.
San Diego’s biotechnology industry has played an integral part in advances in genomics. Our reach extends from the research and tools created by startups during the genomics boom that began in... Read more »
Did you know that Goldie Hawn, David Blaine, and Martha Stewart are coming to San Diego at the end of October to discuss…healthcare? Probably not, maybe because the exclusive TEDMED2009 conference... Read more »